Pfizer gets Rs 85.74 cr income tax demand for FY23, plans to appeal

Pfizer Limited received an income tax assessment order on April 23, 2026 demanding Rs 85.74 crore for FY 2022-23, along with a show cause notice for penalty proceedings. The demand stems from alleged under-reporting of income due to disallowance of certain expenses. The company is evaluating the order and plans to file an appeal and/or stay application, stating it believes it has strong grounds on merits. Pfizer says the order is not expected to have any material impact on its financials or operations at this stage.